Monday 2nd February 2026

Growing to Serve You Better: New Office, CQC Application, and Home Office Licensing Application

​​

Ashley James Medical is entering a transformative new chapter. We are proud to announce a move to a larger commercial headquarters alongside two major regulatory applications: CQC Registration and a Home Office Controlled Drugs Licence. These developments represent a significant leap forward in our operational capabilities, allowing us to provide a more comprehensive, autonomous, and higher-level medical service to our clients.

​

New Headquarters: A Hub for Clinical Excellence

To support our growing operations, we are relocating to a new, larger commercial facility. This move is about more than just extra desk space; it is about infrastructure. The new premises will be selected to meet the rigorous security and storage standards required for our expanded clinical services. It will serve as the central hub for our logistics, clinical governance, and equipment management, ensuring we can deploy fully equipped medical teams faster and more efficiently than ever before.

​

Raising the Standard: CQC Registration

We will soon be submitting our application for registration with the Care Quality Commission (CQC). While we have always operated with strict clinical governance, achieving independent CQC registration will accredit Ashley James Medical as a regulated provider of health and social care. This status will:

​

• Validate our safety and quality standards against the national framework.

• Allow us to undertake a wider range of regulated activities independently.

• Give our clients absolute assurance that they are working with a provider that meets the highest benchmarks of care and safety.

 

Enhanced Capabilities: Home Office Controlled Drugs Licence

In a move that significantly upgrades our clinical scope, we will also be shortly applying for a Home Office Controlled Drugs Licence. Once granted, this licence will allow Ashley James Medical to securely possess, manage, and transport controlled medications.

 

For our clients in the event, film, and private sectors, this is a game-changer. It means our paramedics and clinicians will have direct access to a broader spectrum of pharmacological interventions—such as advanced pain relief and emergency medications—without relying on third-party arrangements.

​

This capability ensures that our medical teams are equipped to handle complex trauma and medical emergencies with the highest level of clinical autonomy.

​

A Word from Leadership

Ashley-James Redfern, CEO & Head of Service at Ashley James Medical, commented:

​

"These applications mark the transition of Ashley James Medical into a fully self-sufficient clinical powerhouse. By securing our own CQC registration and Controlled Drugs licence, we are removing barriers to the care we can provide. We are building an infrastructure that allows our clinicians to deliver hospital-level interventions in pre-hospital environments, all supported by our new dedicated headquarters."

​

We look forward to sharing further updates as we progress through these regulatory milestones. Thank you for your continued trust in Ashley James Medical.

​